デフォルト表紙
市場調査レポート
商品コード
1585639

生物学的安全性試験製品・サービス市場:製品タイプ、用途別-2025-2030年世界予測

Biological Safety Testing Products & Services Market by Product, Test Type, Application - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 190 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
生物学的安全性試験製品・サービス市場:製品タイプ、用途別-2025-2030年世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

生物学的安全性試験製品・サービス市場の2023年の市場規模は56億5,000万米ドルで、2024年には62億8,000万米ドルに達すると予測され、CAGR 11.16%で成長し、2030年には118億6,000万米ドルに達すると予測されています。

生物学的安全性試験製品・サービス市場の範囲は、医薬品、バイオテクノロジー、ヘルスケアで利用される生物学的材料の安全性と有効性を確保するために設計された一連の製品とサービスを包含します。これには、無菌試験、バイオバーデン試験、エンドトキシン試験、不定芽菌試験などの試薬、機器、サービスが含まれます。生物学的安全性試験の必要性は、汚染を防ぎ、製品の完全性を確保し、公衆衛生を守るために、安全基準の遵守を義務付ける厳しい規制枠組みによって強調されています。主な用途は、医薬品や生物製剤の製造、研究環境の拡大、ワクチン製造などです。最終使用主体には、製薬会社、バイオテクノロジー企業、受託研究機関、学術機関が含まれます。市場開拓の主な要因は、バイオテクノロジーおよび製薬分野の拡大、新薬開発への注目の高まり、生物製剤およびバイオシミラーに対する需要の高まりです。さらに、感染症の増加や治療における技術革新の波が、強固な安全性試験実施への需要を後押ししています。自動化・ポイントオブユース生物学的検査技術の開発と採用、新興感染症の予防措置の拡大、先進生物製剤の研究投資の増加などが好機となります。逆に、市場の成長には、検査機器やサービスに関連する高コスト、厳しくダイナミックな規制状況、熟練した人材の必要性が課題となります。事業成長のためには、ハイスループット技術や迅速検査技術などの革新的な検査手法に投資し、AIベースの分析を組み合わせることが価値ある手段となります。新興市場での地理的なリーチを強化するための戦略的パートナーシップも、市場の潜在力を活用する可能性があります。競争市場であるにもかかわらず、同市場は絶え間ないイノベーションと安全性保証の必然的な必要性を特徴としており、製薬・バイオテクノロジー業界にとって重要な要素となっています。

主な市場の統計
基準年[2023] 56億5,000万米ドル
予測年[2024] 62億8,000万米ドル
予測年[2030] 118億6,000万米ドル
CAGR(%) 11.16%

市場力学:急速に進化する生物学的安全性試験製品・サービス市場の主要市場インサイトを公開

生物学的安全性試験製品・サービス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • ライフスタイルの変化に伴う慢性疾患の世界の増加
    • 医薬品開発における適正製造規範の採用に対する政府の介入
    • 医薬品の開発と商業化の増加
  • 市場抑制要因
    • 生物学的安全性試験の熟練専門家の不足
  • 市場機会
    • 組織培養とウイルス安全性試験の研究開発
    • 試験サービスの専門業者へのアウトソーシングの増加
  • 市場の課題
    • 厳しい規制と複雑な手順に関する懸念

ポーターの5つの力:生物学的安全性試験製品・サービス市場をナビゲートする戦略ツール

ポーターのファイブフォースは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:生物学的安全性試験製品・サービス市場における外部からの影響の把握

外部マクロ環境要因は、生物学的安全性試験製品・サービス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析生物学的安全性試験製品・サービス市場における競合情勢の把握

生物学的安全性試験製品・サービス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス生物学的安全性試験製品・サービス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、生物学的安全性試験製品・サービス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨生物学的安全性試験製品・サービス市場における成功への道筋を描く

生物学的安全性試験製品・サービス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界のライフスタイルの変化により慢性疾患の発生率が増加
      • 医薬品開発における適正製造基準の採用に対する政府の介入
      • 医薬品の開発と商業化の増加
    • 抑制要因
      • 生物学的安全性試験の熟練した専門家の不足
    • 機会
      • 組織培養とウイルス安全性試験の研究開発
      • 専門サービスプロバイダーへのテストサービスのアウトソーシングの増加
    • 課題
      • 厳しい規制と複雑な手続きに関する懸念
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 生物学的安全性試験製品・サービス市場:製品別

  • 機器
  • 試薬とキット
  • サービス

第7章 生物学的安全性試験製品・サービス市場テストタイプ別

  • 外来性病原体検出試験
  • バイオバーデン試験
  • 細胞株の認証と特性評価試験
  • エンドトキシン検査
  • 残留宿主汚染検出試験
  • 無菌試験

第8章 生物学的安全性試験製品・サービス市場:用途別

  • 血液および血液由来製品
  • 遺伝子治療
  • 幹細胞
  • 組織および組織ベースの製品
  • ワクチンと治療薬

第9章 南北アメリカの生物学的安全性試験製品・サービス市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の生物学的安全性試験製品・サービス市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの生物学的安全性試験製品・サービス市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Asahi Kasei Corporation
  • Avance Biosciences Inc.
  • BBF Sterilisationsservice GmbH
  • BSL Bioservice Scientific Laboratories Munich GmbH
  • Charles River Laboratories International, Inc.
  • Creative Biogene
  • Eurofins Scientific SE
  • Labquality Oy
  • Lonza Group AG
  • Merck KGaA
  • North American Science Associates, Inc.
  • North American Science Associates, LLC
  • NuAire, Inc.
  • Pace Analytical Services, LLC
  • Samsung Biologics
  • Sartorius AG
  • SGS Societe Generale de Surveillance SA
  • Thermo Fisher Scientific Inc.
  • Toyobo Co., Ltd.
  • UL LLC
  • ViruSure GmbH
  • WuXi Biologics Co., Ltd.
図表

LIST OF FIGURES

  • FIGURE 1. BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CELL LINE AUTHENTICATION & CHARACTERIZATION TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY RESIDUAL HOST CONTAMINATION DETECTION TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BLOOD & BLOOD-BASED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STEM CELL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TISSUE & TISSUE-BASED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY VACCINES & THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 152. BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-A866040826BE

The Biological Safety Testing Products & Services Market was valued at USD 5.65 billion in 2023, expected to reach USD 6.28 billion in 2024, and is projected to grow at a CAGR of 11.16%, to USD 11.86 billion by 2030.

The scope of the Biological Safety Testing Products & Services market encompasses a range of products and services designed to ensure the safety and efficacy of biological materials utilized in pharmaceuticals, biotechnology, and healthcare. These include reagents, instruments, services for sterility testing, bioburden testing, endotoxin testing, and adventitious agent testing among others. The necessity for biological safety testing is underscored by stringent regulatory frameworks mandating compliance with safety standards to prevent contamination, ensure product integrity, and protect public health. The key applications revolve around pharmaceuticals and biologics manufacturing, expanding research environments, and vaccine production. End-use entities include pharmaceutical companies, biotech firms, contract research organizations, and academic institutions. Market growth is predominantly driven by the escalating biotechnology and pharmaceutical sectors, increased focus on new drug development, and heightened demand for biologics and biosimilars. Moreover, growing incidences of infectious diseases and a wave of innovations in medical treatments drive demand for robust safety testing practices. Opportunities arise in the development and adoption of automated and point-of-use biological testing technologies, expanding preventative measures for emerging infectious diseases, and increased investment in research for advanced biologics. Conversely, market growth is challenged by the high costs associated with testing equipment and services, stringent and dynamic regulatory landscapes, and the need for highly skilled personnel. For business growth, investing in innovative testing methodologies, such as high-throughput and rapid testing techniques, coupled with AI-based analytics, represents a valuable avenue. Strategic partnerships to enhance geographical reach in emerging markets could also leverage market potential. Despite being competitive, the market is characterized by its continual innovation and the inevitable need for safety assurance, making it a critical component of the pharmaceutical and biotechnology industries.

KEY MARKET STATISTICS
Base Year [2023] USD 5.65 billion
Estimated Year [2024] USD 6.28 billion
Forecast Year [2030] USD 11.86 billion
CAGR (%) 11.16%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biological Safety Testing Products & Services Market

The Biological Safety Testing Products & Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of chronic diseases with changing lifestyle globally
    • Government intervention in adoption of good manufacturing practices during drug development
    • Increasing development and commercialization of drugs
  • Market Restraints
    • Lack of skilled professionals for biological safety testing
  • Market Opportunities
    • Research and development in tissue cultures and viral safety testing
    • Growing outsourcing of testing services to specialized service providers
  • Market Challenges
    • Concerns regarding strict regulations and complex procedures

Porter's Five Forces: A Strategic Tool for Navigating the Biological Safety Testing Products & Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biological Safety Testing Products & Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biological Safety Testing Products & Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biological Safety Testing Products & Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biological Safety Testing Products & Services Market

A detailed market share analysis in the Biological Safety Testing Products & Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biological Safety Testing Products & Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biological Safety Testing Products & Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biological Safety Testing Products & Services Market

A strategic analysis of the Biological Safety Testing Products & Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biological Safety Testing Products & Services Market, highlighting leading vendors and their innovative profiles. These include Asahi Kasei Corporation, Avance Biosciences Inc., BBF Sterilisationsservice GmbH, BSL Bioservice Scientific Laboratories Munich GmbH, Charles River Laboratories International, Inc., Creative Biogene, Eurofins Scientific SE, Labquality Oy, Lonza Group AG, Merck KGaA, North American Science Associates, Inc., North American Science Associates, LLC, NuAire, Inc., Pace Analytical Services, LLC, Samsung Biologics, Sartorius AG, SGS Societe Generale de Surveillance SA, Thermo Fisher Scientific Inc., Toyobo Co., Ltd., UL LLC, ViruSure GmbH, and WuXi Biologics Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Biological Safety Testing Products & Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instruments, Reagents & Kits, and Services.
  • Based on Test Type, market is studied across Adventitious Agent Detection Tests, Bioburden Tests, Cell Line Authentication & Characterization Tests, Endotoxin Tests, Residual Host Contamination Detection Tests, and Sterility Tests.
  • Based on Application, market is studied across Blood & Blood-Based Products, Gene Therapy, Stem Cell, Tissue & Tissue-Based Products, and Vaccines & Therapeutics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of chronic diseases with changing lifestyle globally
      • 5.1.1.2. Government intervention in adoption of good manufacturing practices during drug development
      • 5.1.1.3. Increasing development and commercialization of drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled professionals for biological safety testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Research and development in tissue cultures and viral safety testing
      • 5.1.3.2. Growing outsourcing of testing services to specialized service providers
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding strict regulations and complex procedures
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biological Safety Testing Products & Services Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Kits
  • 6.4. Services

7. Biological Safety Testing Products & Services Market, by Test Type

  • 7.1. Introduction
  • 7.2. Adventitious Agent Detection Tests
  • 7.3. Bioburden Tests
  • 7.4. Cell Line Authentication & Characterization Tests
  • 7.5. Endotoxin Tests
  • 7.6. Residual Host Contamination Detection Tests
  • 7.7. Sterility Tests

8. Biological Safety Testing Products & Services Market, by Application

  • 8.1. Introduction
  • 8.2. Blood & Blood-Based Products
  • 8.3. Gene Therapy
  • 8.4. Stem Cell
  • 8.5. Tissue & Tissue-Based Products
  • 8.6. Vaccines & Therapeutics

9. Americas Biological Safety Testing Products & Services Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biological Safety Testing Products & Services Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biological Safety Testing Products & Services Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Asahi Kasei Corporation
  • 2. Avance Biosciences Inc.
  • 3. BBF Sterilisationsservice GmbH
  • 4. BSL Bioservice Scientific Laboratories Munich GmbH
  • 5. Charles River Laboratories International, Inc.
  • 6. Creative Biogene
  • 7. Eurofins Scientific SE
  • 8. Labquality Oy
  • 9. Lonza Group AG
  • 10. Merck KGaA
  • 11. North American Science Associates, Inc.
  • 12. North American Science Associates, LLC
  • 13. NuAire, Inc.
  • 14. Pace Analytical Services, LLC
  • 15. Samsung Biologics
  • 16. Sartorius AG
  • 17. SGS Societe Generale de Surveillance SA
  • 18. Thermo Fisher Scientific Inc.
  • 19. Toyobo Co., Ltd.
  • 20. UL LLC
  • 21. ViruSure GmbH
  • 22. WuXi Biologics Co., Ltd.